PALO
Palo Protocol — Nasal
Epithalon 40 mg Nasal — Palo Protocol — coming soon

Palo Protocol: Nasal

Epithalon 40 mg Nasal

Longevity

40 mg in 10 ml · 15 ml bottle

Thirteen times the strength of our oral Epithalon, by a route that bypasses first-pass metabolism. A meaningful difference, and a meaningful reason for caution.

Not available for purchase

What we know

Mechanism
The same tetrapeptide as the oral SKU, at over ten times the strength, via intranasal delivery.
Evidence state
Russian clinical literature of variable quality. No Western regulatory review.
Regulatory note
Not approved in the US. Supplier marks the nasal range 'For Research Use Only'.

Disclaimer

This product is not available for purchase. It has not been evaluated by the FDA and is not intended to diagnose, treat, cure or prevent any disease. Nothing on this page is medical advice. Palo lists this compound for transparency about our supply partnerships; any future availability would run through a licensed prescriber and a compounding pharmacy, not through this website.